1. Home
  2. AMWL vs CBUS Comparison

AMWL vs CBUS Comparison

Compare AMWL & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Well Corporation

AMWL

American Well Corporation

HOLD

Current Price

$5.41

Market Cap

91.2M

Sector

Technology

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.96

Market Cap

208.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMWL
CBUS
Founded
2006
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Agricultural Chemicals
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
91.2M
208.7M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
AMWL
CBUS
Price
$5.41
$1.96
Analyst Decision
Hold
Buy
Analyst Count
7
2
Target Price
$7.42
$9.00
AVG Volume (30 Days)
42.5K
634.3K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
57.06
74.33
EPS
N/A
N/A
Revenue
N/A
$3,639,000.00
Revenue This Year
N/A
$126.00
Revenue Next Year
$4.24
$110.01
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$1.09
52 Week High
$9.15
$4.19

Technical Indicators

Market Signals
Indicator
AMWL
CBUS
Relative Strength Index (RSI) 52.55 36.83
Support Level $4.48 $1.31
Resistance Level $5.83 $2.48
Average True Range (ATR) 0.27 0.32
MACD -0.05 -0.16
Stochastic Oscillator 50.00 14.73

Price Performance

Historical Comparison
AMWL
CBUS

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: